Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    September 2018
  1. BAIRD JR, Bell RB, Troesch V, Friedman DJ, et al
    Evaluation of explant responses to STING ligands: personalized immunosurgical therapy for head and neck squamous cell carcinoma.
    Cancer Res. 2018 Sep 17. pii: 0008-5472.CAN-18-1652.
    PubMed     Text format     Abstract available


  2. KAJIWARA C, Fumoto K, Kimura H, Nojima S, et al
    p63-dependent Dickkopf3 expression promotes esophageal cancer cell proliferation via CKAP4.
    Cancer Res. 2018 Sep 4. pii: 0008-5472.CAN-18-1749.
    PubMed     Text format     Abstract available


    August 2018
  3. KRISHNA S, Ulrich P, Wilson E, Parikh F, et al
    Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0163.
    PubMed     Text format     Abstract available


  4. READ ML, Modasia B, Fletcher A, Thompson RJ, et al
    PTTG and PBF functionally interact with p53 and predict overall survival in head and neck cancer.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0855.
    PubMed     Text format     Abstract available


    July 2018
  5. DORTA-ESTREMERA S, Chin RL, Sierra G, Nicholas C, et al
    Mucosal HPV E6/E7 peptide vaccination in combination with immune checkpoint modulation induces regression of HPV+ oral cancers.
    Cancer Res. 2018 Jul 27. pii: 0008-5472.CAN-18-0892.
    PubMed     Text format     Abstract available


    June 2018
  6. ZHANG J, Chen T, Yang X, Cheng H, et al
    Attenuated TRAF3 fosters alternative activation of NF-kappaB and reduced expression of anti-viral interferon, TP53, and RB to promote HPV-positive head and neck cancers.
    Cancer Res. 2018 Jun 19. pii: 0008-5472.CAN-17-0642.
    PubMed     Text format     Abstract available


  7. BROUWER AF, Eisenberg MC, Meza R
    Case Studies of Gastric, Lung, and Oral Cancer Connect Etiologic Agent Prevalence to Cancer Incidence.
    Cancer Res. 2018;78:3386-3396.
    PubMed     Text format     Abstract available


    May 2018
  8. KUMAR D, New J, Vishwakarma V, Joshi R, et al
    Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
    Cancer Res. 2018 May 16. pii: 0008-5472.CAN-17-1076.
    PubMed     Text format     Abstract available


  9. GOU Q, Gao L, Nie X, Pu W, et al
    Long noncoding RNA AB074169 inhibits cell proliferation via modulation of KHSRP-mediated p21 expression in papillary thyroid carcinoma.
    Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-3766.
    PubMed     Text format     Abstract available


    February 2018
  10. BRAND TM, Hartmann S, Bhola NE, Li H, et al
    Crosstalk signaling between HER3 and HPV16 E6 and E7 mediates resistance to PI3K inhibitors in head and neck cancer.
    Cancer Res. 2018 Feb 12. pii: 0008-5472.CAN-17-1672.
    PubMed     Text format     Abstract available


    December 2017

  11. Correction: JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
    Cancer Res. 2017;77:7136.
    PubMed     Text format    


  12. ORLACCHIO A, Ranieri M, Brave M, Arciuch VA, et al
    SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance.
    Cancer Res. 2017;77:6914-6926.
    PubMed     Text format     Abstract available


  13. HU F, Martin H, Martinez A, Everitt J, et al
    Distinct Angiogenic Changes during Carcinogenesis Defined by Novel Label-Free Dark-Field Imaging in a Hamster Cheek Pouch Model.
    Cancer Res. 2017;77:7109-7119.
    PubMed     Text format     Abstract available


  14. GADHIKAR MA, Zhang J, Shen L, Rao X, et al
    CDKN2A/p16 deletion in head and neck cancer cells is associated with Cdk2 activation, replication stress, and vulnerability to Chk1 inhibition.
    Cancer Res. 2017 Dec 11. pii: 0008-5472.CAN-17-2802.
    PubMed     Text format     Abstract available


  15. PETERS BA, Wu J, Pei Z, Yang L, et al
    Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers.
    Cancer Res. 2017;77:6777-6787.
    PubMed     Text format     Abstract available


  16. KELLEY DZ, Flam EL, Izumchenko E, Danilova LV, et al
    Integrated Analysis of Whole-Genome ChIP-Seq and RNA-Seq Data of Primary Head and Neck Tumor Samples Associates HPV Integration Sites with Open Chromatin Marks.
    Cancer Res. 2017;77:6538-6550.
    PubMed     Text format     Abstract available


    October 2017
  17. SUGASE T, Takahashi T, Serada S, Fujimoto M, et al
    SOCS1 gene therapy improves radiosensitivity and enhances irradiation-induced DNA damage in esophageal squamous cell carcinoma.
    Cancer Res. 2017 Oct 17. pii: canres.1525.2017.
    PubMed     Text format     Abstract available


  18. GUO T, Sakai A, Afsari B, Considine M, et al
    A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers.
    Cancer Res. 2017;77:5248-5258.
    PubMed     Text format     Abstract available


    September 2017
  19. NEW J, Arnold L, Ananth M, Alvi S, et al
    Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target.
    Cancer Res. 2017 Sep 28. pii: canres.1077.2017.
    PubMed     Text format     Abstract available


  20. YUAN J, Jiang YY, Mayakonda A, Huang M, et al
    Super-enhancers promote transcriptional dysregulation in nasopharyngeal carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1143.2017.
    PubMed     Text format     Abstract available


  21. MATTOX A, Lee J, Westra WH, Pierce RH, et al
    PD-1 expression in head and neck squamous cell carcinomas derives primarily from functionally anergic CD4+ TILs in the presence of PD-L1+ TAMs.
    Cancer Res. 2017 Sep 25. pii: canres.3453.2016.
    PubMed     Text format     Abstract available


  22. KANSY BA, Concha-Benavente F, Srivastava RM, Jie HB, et al
    PD-1 status in CD8+ T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer.
    Cancer Res. 2017 Sep 13. pii: canres.3167.2016.
    PubMed     Text format     Abstract available


  23. LAU MC, Ng KY, Wong TL, Tong M, et al
    FSTL1 promotes metastasis and chemoresistance in esophageal squamous cell carcinoma through NFkappaB-BMP signaling crosstalk.
    Cancer Res. 2017 Sep 7. pii: canres.1411.2017.
    PubMed     Text format     Abstract available


    July 2017
  24. EDWARDS ZC, Trotter EW, Torres-Ayuso P, Chapman P, et al
    Survival of head and neck cancer cells relies upon LZK kinase-mediated stabilization of mutant p53.
    Cancer Res. 2017 Jul 31. pii: canres.0267.2017.
    PubMed     Text format     Abstract available


    June 2017

  25. Correction: Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal-Epithelial Transition in Head and Neck Cancer Cells.
    Cancer Res. 2017;77:3127.
    PubMed     Text format    



  26. Correction: Chromosome Instability Modulated by BMI1-AURKA Signaling Drives Progression in Head and Neck Cancer.
    Cancer Res. 2017;77:3125-3126.
    PubMed     Text format    


    May 2017
  27. PRAT A, Navarro A, Pare L, Reguart N, et al
    Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma and melanoma.
    Cancer Res. 2017 May 9. pii: canres.3556.2017.
    PubMed     Text format     Abstract available


  28. HUANG D, Song S, Wu ZZ, Wu W, et al
    Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages.
    Cancer Res. 2017 May 8. pii: canres.2706.2016.
    PubMed     Text format     Abstract available


  29. TAMURA T, Ichikawa T, Nakahata S, Kondo Y, et al
    Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential.
    Cancer Res. 2017;77:2363-2374.
    PubMed     Text format     Abstract available


    April 2017
  30. ZOU M, Baitei EY, BinEssa HA, Al-Mohanna FA, et al
    Cyp24a1 Attenuation Limits Progression of BrafV600E -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720.
    Cancer Res. 2017;77:2161-2172.
    PubMed     Text format     Abstract available


    February 2017
  31. CHIU GS, Maj MA, Rizvi S, Dantzer R, et al
    Pifithrin-mu Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function.
    Cancer Res. 2017;77:742-752.
    PubMed     Text format     Abstract available


    January 2017
  32. TANG Q, Cheng B, Xie M, Chen Y, et al
    Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma.
    Cancer Res. 2017;77:532-544.
    PubMed     Text format     Abstract available


  33. ZHENG LS, Yang JP, Cao Y, Peng LX, et al
    SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor.
    Cancer Res. 2017;77:579-589.
    PubMed     Text format     Abstract available


    April 2016
  34. LI L, Li C, Wang S, Wang Z, et al
    Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype.
    Cancer Res. 2016;76:1770-80.
    PubMed     Text format     Abstract available


  35. JOLLY LA, Novitskiy S, Owens P, Massoll N, et al
    Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss.
    Cancer Res. 2016;76:1804-13.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: